Crossmark

The impact of Medicare part D on income-related inequality in pharmaceutical expenditure

Crossref DOI link: https://doi.org/10.1186/s12939-019-0955-9

Published Online: 2019-04-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Carvalho, Natalie https://orcid.org/0000-0002-5599-2209
Petrie, Dennis

Chen, Linkun

Salomon, Joshua A.

Clarke, Philip
License Information

Text and Data Mining valid from 2019-04-16
More Information

Article History

Received: 2 September 2018

Accepted: 29 March 2019

First Online: 16 April 2019

Authors’ information

: The findings and conclusions expressed in this paper are entirely those of the authors and should not be attributed to the institutions to which the authors are affiliated.

: This analysis used de-identified secondary data from the Medical Expenditures Panel Survey (MEPS), as such did not require additional ethics approval.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.